Global

Search

Filter by category
Filter by category
reset filters
respichamber side angle

RESPICHAMBER* Chamber

This spacer is static resistant, includes optional attachable face masks and can be used with all commonly prescribed MDIs. 

View details
Horizontal view of RespiChamber

RESPICHAMBER* HOSPITAL Autoclavable Chamber

Designed for use in hospitals, this chamber is autoclavable for multi-patient use and is static resistant. 

View details
Using Functional Respiratory Imaging

Using Functional Respiratory Imaging (FRI) to Compare Predicted Airway Deposition Between Pressurized Metered Dose Inhaler (pMDI) with AeroChamber Plus* Flow-Vu* Valved Holding Chamber (VHC) and Two Dry Powder Inhalers (DPIs) in a COPD patient

This study was presented at the Drug Delivery to the Lungs Conference, 2022.

View details
view of aerocount dose counter from top angle

AEROCOUNT* Dose Counter (TMAI)

Provides patients with a visual indication of remaining medication in their pressurized Metered Dose Inhaler (MDI).

View details
AeroChamber MV horizontal view from the left

AEROCHAMBER* MV Holding Chamber

Use in a mechanical ventilator circuit or with a resuscitation bag.

View details
AeroChamber Mini angled horizontal, viewed from the left

AEROCHAMBER* mini Anti-Static Holding Chamber

Small volume chamber used in a mechanical ventilator circuit or with a resuscitation bag.

View details
Ombra tabletop compressor shown with the AEROECLIPSE* XL BAN* Nebulizer

OMBRA* Table Top Compressor

The OMBRA* Table Top Compressor system is easy to use and durable for treatments at home.

View details
5 ombra air filters

Ombra* Air Filter

Replacement air filters for use with OMBRA* Table Top Compressors.

View details
lifestyle doctor and patient

Inspiratory Profiles from Volunteer Adults who Have Read the Patient Instructions for Use for Two Passive Dry Powder Inhalers (DPIs) Compared with those from a Pressurized Metered Dose Inhaler with Valved Holding Chamber (pMDI+VHC)

This study was presented at the Drug Delivery to the Lungs, 2022.

View details
Elderly woman coughing

Dry Powder Inhalers (DPIs) vs Metered Dose Inhaler (MDI) with Valved Spacer : Using Functional Respiratory Imaging (FRI) to Assess Modelled Lung Deposition in a COPD patient

  • The FRI deposition profiles highlight that the MDI/AeroChamber Plus* Flow-Vu* VHC delivered a significantly greater percentage of drug to the lung region than either of the two DPIs, irrespective of flow rate.
  • This was reflected in much higher modelled oropharyngeal deposition for the two DPIs.
  • The influence of inhalation flow profile was significant for one of the DPIs.
View details
Patient Centered Considerations when Selecting

Patient Centered Considerations when Selecting an Oscillating Positive Expiratory Pressure (OPEP) Device

Efficacy is a major aspect when selecting an OPEP device for airway clearance.

This study was presented at the North American Cystic Fibrosis Conference 2022.

View details

European Medical Journal: How a Novel Portable Spacer Benefits Patients with Respiratory Disease, the Healthcare System, and the Environment

View details

Product Resources for Healthcare Professionals

View our product videos, download our how-to-use instructions, and counseling materials.
View details
reduce your carbon footprint

Maximizing the benefit from the inhaler in order to minimize carbon footprint.

Depending on the pMDI/spacer system chosen the delivery of medication can vary significantly and as a result will have implications on the potential carbon footprint.

In this case, the use of the AeroChamber Plus* Flow-Vu* VHC could potentially reduce the carbon footprint by three fold compared to the alternative spacers.

By maximizing the amount of each puff reaching the lungs the patient is likely to be able to get relief sooner and reduce the amount of puffs needed.

View details
reduce your carbon footprint

Maximizing the benefit from the inhaler in order to minimize carbon footprint

Depending on the pMDI/spacer system chosen the delivery of medication can vary significantly and as a result will have implications on the potential carbon footprint.

In this case, the use of the AeroChamber Plus* Flow-Vu* VHC could potentially reduce the carbon footprint by three fold compared to the alternative spacers.

By maximizing the amount of each puff reaching the lungs the patient is likely to be able to get relief sooner and reduce the amount of puffs needed.

View details

Helpful Resources

View details